Overview

Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets

Status:
COMPLETED

Trial end date:
2024-03-05

Target enrollment:

Participant gender:

Summary

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Empagliflozin/ Metformin HCl 12.5mg/1000mg film-coated tablets (12.5mg Empagliflozin / 1000mg Metformin HCl) versus Synjardy® 12.5mg/1000mg film-coated tablets (12.5mg Empagliflozin/ 1000mg Metformin HCl) in healthy subjects under fed conditions.

Phase:

PHASE1

Details

Lead Sponsor:

Humanis Saglık Anonim Sirketi

Treatments:

Metformin